Sanofi CEO believes company poised for growth from new drugs
WEB1 day ago · NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent ...
Lenders Line Up Over €10 Billion for Sanofi Health Unit Buyout
WEB19 hours ago · September 24, 2024 at 7:23 AM EDT. Save. Banks and other lenders are lining up more than €10 billion ($11.1 billion) of debt to back a buyout of Sanofi SA’s consumer health division, as one of ...
Latest Sanofi Press Releases and News | Sanofi
WEBStay informed with the latest Sanofi press releases and news updates. Discover new developments in healthcare and pharmaceuticals with Sanofi.
Sanofi wins US approval for drug combination to treat multiple
WEBStory by Reuters. • 9h. -Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed multiple myeloma, where it has previously been ...
Sanofi pushes ahead with €20bn consumer healthcare spin-off
WEBJun 2, 2024 · The move makes Sanofi the latest Big Pharma company to seek to separate low-margin, consumer businesses from divisions focused on innovative new medicines that offer higher returns.
Sanofi Pipeline Transformation to Accelerate Growth Driven by …
WEBDec 7, 2002 · Sanofi’s R&D will lead to a 50% increase in the number of Phase 3 studies between 2023 and 2025, creating the greatest pipeline momentum in Sanofi’s history. The company’s commitment to R&D will also support an expected 25 mid- to late-stage read-outs and up to 19 regulatory submissions for its pharma assets in the next two years.
Sanofi Enters Next Chapter of Play to Win Strategy | Sanofi
WEBOct 27, 2005 · Sanofi today provided a comprehensive update regarding its Play to Win strategy. This strategy continues to focus on the critical goals of executing transformative medicine and vaccines launches, driving agile and efficient resource deployment and enhancing R&D productivity.
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) …
WEBMar 16, 2020 · Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced they have started a clinical program evaluating Kevzara ® (sarilumab) in patients hospitalized with severe COVID-19...
Sanofi to overhaul US operations of vaccines, cut jobs
WEBApril 18 (Reuters) - French drugmaker Sanofi (SASY.PA) said on Thursday it would restructure the U.S. commercial operations for its vaccines and cut an undisclosed number of jobs.
Press Room - Sanofi US News
WEB5 days ago · Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA. Read more. Sep 13, 2024.